These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25732908)

  • 1. Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockade.
    Sanada H; Yoneda M; Yatabe J; Williams SM; Bartlett J; White MJ; Gordon LN; Felder RA; Eisner GM; Armando I; Jose PA
    Pharmacogenomics J; 2016 Feb; 16(1):3-9. PubMed ID: 25732908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
    Vandell AG; Lobmeyer MT; Gawronski BE; Langaee TY; Gong Y; Gums JG; Beitelshees AL; Turner ST; Chapman AB; Cooper-DeHoff RM; Bailey KR; Boerwinkle E; Pepine CJ; Liggett SB; Johnson JA
    Hypertension; 2012 Oct; 60(4):957-64. PubMed ID: 22949529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants of GRK4 influence circadian rhythm of blood pressure and response to candesartan in hypertensive patients.
    Cao N; Tang H; Tian M; Gong X; Xu Z; Zhou B; Lan C; Chen C; Qu S; Zheng S; Ren H; Fan C; Jose PA; Zeng C; Xia T
    Clin Exp Hypertens; 2021 Oct; 43(7):597-603. PubMed ID: 33899625
    [No Abstract]   [Full Text] [Related]  

  • 4. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.
    Bhatnagar V; O'Connor DT; Brophy VH; Schork NJ; Richard E; Salem RM; Nievergelt CM; Bakris GL; Middleton JP; Norris KC; Wright J; Hiremath L; Contreras G; Appel LJ; Lipkowitz MS;
    Am J Hypertens; 2009 Mar; 22(3):332-8. PubMed ID: 19119263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.
    Sanada H; Yatabe J; Midorikawa S; Hashimoto S; Watanabe T; Moore JH; Ritchie MD; Williams SM; Pezzullo JC; Sasaki M; Eisner GM; Jose PA; Felder RA
    Clin Chem; 2006 Mar; 52(3):352-60. PubMed ID: 16439609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive insights in GRK4 and hypertension: From mechanisms to potential therapeutics.
    Yang J; Hall JE; Jose PA; Chen K; Zeng C
    Pharmacol Ther; 2022 Nov; 239():108194. PubMed ID: 35487286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study of G protein-coupled receptor kinase 4 gene variants with essential hypertension in northern Han Chinese.
    Wang Y; Li B; Zhao W; Liu P; Zhao Q; Chen S; Li H; Gu D
    Ann Hum Genet; 2006 Nov; 70(Pt 6):778-83. PubMed ID: 17044852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.
    Jose PA; Soares-da-Silva P; Eisner GM; Felder RA
    Biochim Biophys Acta; 2010 Dec; 1802(12):1259-67. PubMed ID: 20153824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.
    Rayner B; Ramesar R
    Int J Mol Sci; 2015 Mar; 16(3):5741-9. PubMed ID: 25775155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional genomics of the dopaminergic system in hypertension.
    Zeng C; Sanada H; Watanabe H; Eisner GM; Felder RA; Jose PA
    Physiol Genomics; 2004 Nov; 19(3):233-46. PubMed ID: 15548830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension.
    Speirs HJ; Katyk K; Kumar NN; Benjafield AV; Wang WY; Morris BJ
    J Hypertens; 2004 May; 22(5):931-6. PubMed ID: 15097232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins.
    Zhu H; Lu Y; Wang X; Treiber FA; Harshfield GA; Snieder H; Dong Y
    Am J Hypertens; 2006 Jan; 19(1):61-6. PubMed ID: 16461192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.
    Toh R; Ishida T; Nishimura K; Nonaka H; Inoue Y; Kitagawa Y; Suematsu M; Miki T; Emoto N; Hirata K
    Hypertens Res; 2012 Nov; 35(11):1080-6. PubMed ID: 22786569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants in genes involved in functional pathways associated with hypertension in African Americans.
    Martinez Cantarin MP; Ertel A; Deloach S; Fortina P; Scott K; Burns TL; Falkner B
    Clin Transl Sci; 2010 Dec; 3(6):279-86. PubMed ID: 21167003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human GRK4γ142V Variant Promotes Angiotensin II Type I Receptor-Mediated Hypertension via Renal Histone Deacetylase Type 1 Inhibition.
    Wang Z; Zeng C; Villar VA; Chen SY; Konkalmatt P; Wang X; Asico LD; Jones JE; Yang Y; Sanada H; Felder RA; Eisner GM; Weir MR; Armando I; Jose PA
    Hypertension; 2016 Feb; 67(2):325-34. PubMed ID: 26667412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of GRK4 in the regulation of arterial AT1 receptor in hypertension.
    Chen K; Fu C; Chen C; Liu L; Ren H; Han Y; Yang J; He D; Zhou L; Yang Z; Zhang L; Jose PA; Zeng C
    Hypertension; 2014 Feb; 63(2):289-96. PubMed ID: 24218433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretics enhance effects of increased dose of candesartan on ambulatory blood pressure reduction in Japanese patients with uncontrolled hypertension treated with medium-dose angiotensin II receptor blockers.
    Sakima A; Kita T; Nakada S; Yokota N; Tamaki N; Etoh T; Shimokubo T; Kitamura K; Takishita S; Ohya Y
    Clin Exp Hypertens; 2014; 36(1):40-5. PubMed ID: 23713902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-protein receptor kinase 4 polymorphism and response to antihypertensive therapy.
    Muskalla AM; Suter PM; Saur M; Nowak A; Hersberger M; Krayenbuehl PA
    Clin Chem; 2014 Dec; 60(12):1543-8. PubMed ID: 25301854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of the angiotensin II type 1 receptor gene affect antihypertensive response to angiotensin receptor blockers in hypertensive Chinese.
    Gong HT; Ma XL; Chen BX; Xu XY; Li Q; Guo CX; Du FH
    Genet Mol Res; 2013 Jun; 12(2):2068-75. PubMed ID: 23913386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.